Contraceptives (Depo-Provera)

Study Indicates an Unwillingness to Tolerate Side Effects

Published in Women's Health Weekly, August 5th, 1996

Slightly over 71 percent of American women in a study of an injectable contraceptive discontinued it within the first year due to side effects.

According to a study published in the August 1996 issue of Obstetrics and Gynecology, this is the first U.S. study to examine method-related experiences and the acceptability of injectable contraception among American women. The women who stopped using this method most often reported heavier and more frequent bleeding, or amenorrhea (loss of period), increased cramping, weight gain, headaches, depression, and nervousness.

The contraceptive depot medroxyprogesterone acetate (DMPA), marketed as Depo-Provera by...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly

Source: Women's Health Weekly (1996-08-05)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry